Arcellx, Inc.
Arcellx, Inc.（ACLX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ACLX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
22
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Arcellx, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ACLX 季度内部人买卖趋势
ACLX 内幕交易卖出 · ACLX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ACLX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ACLX 高管卖出股份 · ACLX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 28, 2026 | Carroll Jill Director | Other | 1,479,148 | $170.10M⚡ | Form 4 |
| Apr 28, 2026 | Behbahani Ali Director | Other | 2,706 | $311K | Form 4 |
| Apr 28, 2026 | Lubner David Charles Director | Other | 21,659 | $2.49M⚡ | Form 4 |
| Apr 28, 2026 | Galligan Andrew H Director | Other | 5,000 | $575K | Form 4 |
| Apr 28, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Other | 5,000 | $575K | Form 4 |
| Apr 28, 2026 | Heery Christopher CHIEF MEDICAL OFFICER | Other | 23,749 | $2.73M⚡ | Form 4 |
| Apr 28, 2026 | Elghandour Rami SEE REMARKS · Director | Other | 101,164 | $11.63M⚡ | Form 4 |
| Apr 16, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Option | 2,110 | $18K | Form 4 |
| Apr 15, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Option | 36,000 | $312K | Form 4 |
| Mar 17, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Gift | 5,000 | — | Form 4 |
| Mar 4, 2026 | Elghandour Rami SEE REMARKS · Director | Gift | 101,164 | — | Form 4 |
| Feb 27, 2026 | Elghandour Rami SEE REMARKS · Director | Sale | 89,916 | $10.24M⚡ | Form 4 |
| Feb 25, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale | 11,219 | $1.28M⚡ | Form 4 |
| Feb 19, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale | 2,879 | $195K | Form 4 |
| Feb 19, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale | 5,405 | $371K | Form 4 |
| Feb 19, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale | 100 | $7K | Form 4 |
| Feb 17, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale | 7,141 | $494K | Form 4 |
| Feb 17, 2026 | Gilson Michelle CHIEF FINANCIAL OFFICER | Sale | 4,150 | $291K | Form 4 |
| Feb 11, 2026 | Elghandour Rami SEE REMARKS · Director | Gift | 198,000 | — | Form 4 |
| Feb 11, 2026 | Elghandour Rami SEE REMARKS · Director | Gift | 218,500 | — | Form 4 |
| Jan 20, 2026 | Lubner David Charles Director | Option | 6,000 | $38K | Form 4 |
| Jan 20, 2026 | Lubner David Charles Director | Sale | 6,000 | $450K | Form 4 |
| Jan 14, 2026 | Heery Christopher CHIEF MEDICAL OFFICER | Sale | 5,882 | $403K | Form 4 |
| Jan 13, 2026 | Heery Christopher CHIEF MEDICAL OFFICER | Sale | 7,437 | $487K | Form 4 |
| Jan 12, 2026 | Heery Christopher CHIEF MEDICAL OFFICER | Sale | 6,131 | $393K | Form 4 |
Heery Christopher
CHIEF MEDICAL OFFICER
日期
Apr 28
股数
23,749
均价
$115.00
总金额
$2.73M ⚡
Elghandour Rami
SEE REMARKS · Director
日期
Apr 28
股数
101,164
均价
$115.00
总金额
$11.63M ⚡
Elghandour Rami
SEE REMARKS · Director
日期
Feb 27
股数
89,916
均价
$113.92
总金额
$10.24M ⚡
Gilson Michelle
CHIEF FINANCIAL OFFICER
日期
Feb 25
股数
11,219
均价
$113.82
总金额
$1.28M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ACLX 内幕交易
ACLX 内幕交易
Arcellx, Inc.（ACLX）内幕交易数据来源于公司内部人（包括Gilson Michelle (CHIEF FINANCIAL OFFICER), Elghandour Rami (SEE REMARKS · Director), Heery Christopher (CHIEF MEDICAL OFFICER)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ACLX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Arcellx, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ACLX 内幕交易 · 5个问题Arcellx, Inc.（ACLX）的内部人包括高管和董事，如Gilson Michelle (CHIEF FINANCIAL OFFICER), Elghandour Rami (SEE REMARKS · Director), Heery Christopher (CHIEF MEDICAL OFFICER)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026